Notes from the Field: Nitazene-Related Deaths - Tennessee, 2019-2021

doi:10.15585/mmwr.mm7137a5

. 2022 Sep 16;71(37):1196-1197.

doi: 10.15585/mmwr.mm7137a5.

Notes from the Field: Nitazene-Related Deaths - Tennessee, 2019-2021

Allison Roberts¹, Jessica Korona-Bailey¹, Sutapa Mukhopadhyay¹

Affiliations

PMID: 36107790
PMCID: PMC9484803
DOI: 10.15585/mmwr.mm7137a5

Notes from the Field: Nitazene-Related Deaths - Tennessee, 2019-2021

Allison Roberts et al. MMWR Morb Mortal Wkly Rep. 2022.

. 2022 Sep 16;71(37):1196-1197.

doi: 10.15585/mmwr.mm7137a5.

Authors

Allison Roberts¹, Jessica Korona-Bailey¹, Sutapa Mukhopadhyay¹

Affiliation

¹ Office of Informatics and Analytics, Tennessee Department of Health.

PMID: 36107790
PMCID: PMC9484803
DOI: 10.15585/mmwr.mm7137a5

No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Cited by

Nitazenes: An Old Drug Class Causing New Problems.
Schwarz ES, Dicker F, Lothet E, Spungen H, Levine M. Schwarz ES, et al. Mo Med. 2025 Jul-Aug;122(4):329-333. Mo Med. 2025. PMID: 40787029 Free PMC article.
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients.
Amaducci A, Aldy K, Campleman SL, Li S, Meyn A, Abston S, Culbreth RE, Krotulski A, Logan B, Wax P, Brent J, Manini AF; Toxicology Investigators Consortium Fentalog Study Group. Amaducci A, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2331264. doi: 10.1001/jamanetworkopen.2023.31264. JAMA Netw Open. 2023. PMID: 37642962 Free PMC article.
Associations between opioid overdose deaths and drugs confiscated by law enforcement and submitted to crime laboratories for analysis, United States, 2014-2019: an observational study.
Zibbell JE, Aldridge A, Grabenauer M, Heller D, Clarke SD, Pressley D, McDonald HS. Zibbell JE, et al. Lancet Reg Health Am. 2023 Aug 5;25:100569. doi: 10.1016/j.lana.2023.100569. eCollection 2023 Sep. Lancet Reg Health Am. 2023. PMID: 37583649 Free PMC article.
Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention.
Jain L, Kaur J, Ayub S, Ansari D, Ahmed R, Dada AQ, Ahmed S. Jain L, et al. World J Psychiatry. 2024 Jun 19;14(6):760-766. doi: 10.5498/wjp.v14.i6.760. eCollection 2024 Jun 19. World J Psychiatry. 2024. PMID: 38984339 Free PMC article.
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries.
Bade R, Nadarajan D, Hall W, Brown JA; NPS Wastewater Consortium; Schumann J. Bade R, et al. Addiction. 2025 Sep;120(9):1739-1746. doi: 10.1111/add.70027. Epub 2025 Mar 18. Addiction. 2025. PMID: 40099983 Free PMC article.

References

1. Vandeputte MM, Van Uytfanghe K, Layle NK, St Germaine DM, Iula DM, Stove CP. Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “nitazene” 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci 2021;12:1241–51. 10.1021/acschemneuro.1c00064 - DOI - PubMed
1. Expert Committee on Drug Dependence. Critical review report: isotonitazene. Geneva, Switzerland: World Health Organization, Expert Committee on Drug Dependence; 2022. https://www.who.int/docs/default-source/controlled-substances/43rd-ecdd/...
1. Vandeputte MM, Krotulski AJ, Walther D, et al. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid. Arch Toxicol 2022;96:1845–63. 10.1007/s00204-022-03276-4 - DOI - PubMed
1. Public Health Ontario. Novel non-fentanyl synthetic opioids: risk assessment and implications for practice. Toronto, ON: Ontario Agency for Health Protection and Promotion, Public Health Ontario; 2021. https://www.publichealthontario.ca/-/media/documents/e/2021/evidence-bri...
1. Diversion Control Division. DEA Tox toxicology testing program. Springfield, Virginia: US Department of Justice, Drug Enforcement Administration; 2022. Accessed May 26, 2022. https://www.deadiversion.usdoj.gov/dea_tox/index.html

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov

[1] Vandeputte MM, Van Uytfanghe K, Layle NK, St Germaine DM, Iula DM, Stove CP. Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “nitazene” 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci 2021;12:1241–51. 10.1021/acschemneuro.1c00064 - DOI - PubMed

[2] Vandeputte MM, Van Uytfanghe K, Layle NK, St Germaine DM, Iula DM, Stove CP. Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “nitazene” 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci 2021;12:1241–51. 10.1021/acschemneuro.1c00064 - DOI - PubMed

[3] Expert Committee on Drug Dependence. Critical review report: isotonitazene. Geneva, Switzerland: World Health Organization, Expert Committee on Drug Dependence; 2022. https://www.who.int/docs/default-source/controlled-substances/43rd-ecdd/...

[4] Expert Committee on Drug Dependence. Critical review report: isotonitazene. Geneva, Switzerland: World Health Organization, Expert Committee on Drug Dependence; 2022. https://www.who.int/docs/default-source/controlled-substances/43rd-ecdd/...

[5] Vandeputte MM, Krotulski AJ, Walther D, et al. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid. Arch Toxicol 2022;96:1845–63. 10.1007/s00204-022-03276-4 - DOI - PubMed

[6] Vandeputte MM, Krotulski AJ, Walther D, et al. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid. Arch Toxicol 2022;96:1845–63. 10.1007/s00204-022-03276-4 - DOI - PubMed

[7] Public Health Ontario. Novel non-fentanyl synthetic opioids: risk assessment and implications for practice. Toronto, ON: Ontario Agency for Health Protection and Promotion, Public Health Ontario; 2021. https://www.publichealthontario.ca/-/media/documents/e/2021/evidence-bri...

[8] Public Health Ontario. Novel non-fentanyl synthetic opioids: risk assessment and implications for practice. Toronto, ON: Ontario Agency for Health Protection and Promotion, Public Health Ontario; 2021. https://www.publichealthontario.ca/-/media/documents/e/2021/evidence-bri...

[9] Diversion Control Division. DEA Tox toxicology testing program. Springfield, Virginia: US Department of Justice, Drug Enforcement Administration; 2022. Accessed May 26, 2022. https://www.deadiversion.usdoj.gov/dea_tox/index.html

[10] Diversion Control Division. DEA Tox toxicology testing program. Springfield, Virginia: US Department of Justice, Drug Enforcement Administration; 2022. Accessed May 26, 2022. https://www.deadiversion.usdoj.gov/dea_tox/index.html

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Notes from the Field: Nitazene-Related Deaths - Tennessee, 2019-2021

Affiliation

Notes from the Field: Nitazene-Related Deaths - Tennessee, 2019-2021

Authors

Affiliation

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical